Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BDX · as of Mar 31, 2025
Ownership Breakdown
1,654
Institutional Holders
▼ 22 vs Q4
$59.47B
Total Inst. Value
▲ $875.80M vs Q4
362.30M
Shares Outstanding
freeFloat 99.81%
259.43M
13F Shares Held
▲ 925,442 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BDX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 28.00M | 9.71% | 9.71% | $6.41T | May 9, 2025 | ▲ 1.26M |
BLACKROCK, INC. surgical & medical instruments & apparatus | 23.89M | 8.28% | 8.28% | $5.47T | May 2, 2025 | ▼ 92.5K |
STATE STREET CORP surgical & medical instruments & apparatus | 13.99M | 4.85% | 4.85% | $3.21T | May 15, 2025 | ▼ 94.8K |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. surgical & medical instruments & apparatus | 12.58M | 4.36% | 4.36% | $2.88T | May 14, 2025 | ▲ 448.6K |
PRICE T ROWE ASSOCIATES INC /MD/ surgical & medical instruments & apparatus | 11.31M | 3.92% | 3.92% | $2.59T | May 14, 2025 | ▼ 1.03M |
MORGAN STANLEY surgical & medical instruments & apparatus | 8.59M | 2.98% | 2.98% | $1.97T | May 15, 2025 | ▼ 1.65M |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ surgical & medical instruments & apparatus | 6.84M | 2.37% | 2.37% | $1.57T | May 2, 2025 | ▲ 668.0K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 6.48M | 2.25% | 2.25% | $1.48T | May 13, 2025 | ▲ 128.0K |
FIRST EAGLE INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 5.52M | 1.91% | 1.91% | $1.26T | May 12, 2025 | ▲ 1.09M |
GENERATION INVESTMENT MANAGEMENT LLP surgical & medical instruments & apparatus | 5.30M | 1.84% | 1.84% | $1.21T | May 15, 2025 | ▼ 518.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
29
Increased
+9.68M shares2
New Positions
first time holders19
Decreased
−7.59M shares0
Sold Out
fully exitedNet shares change (top 50)
+2.09M
+9.68M / −7.59M
Net new holders
+12
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BDX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
6
Sell transactions
0.83
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Polen Thomas E Jr Chairman, CEO and President | Jun 1, 2026 | Sale | 2,764 | $146.35 | $404.5K | 110.2K | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Jun 1, 2026 | D-Return | 17,445 | $146.15 | $2.55M | 108.2K | Form 4 ↗ |
Menziuso Peter EVP and President, BDI | Jun 1, 2026 | Award | 14,258 | — | — | 14.3K | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | May 26, 2026 | Sale | 75 | $147.35 | $11.1K | 21.1K | Form 4 ↗ |
Huffines Robert Luther director | May 8, 2026 | Award | 210 | — | — | 404 | Form 4 ↗ |
Byington Carrie L director | May 8, 2026 | Award | 105 | — | — | 3.7K | Form 4 ↗ |
Roque Vitor EVP & Chief Financial Officer | May 7, 2026 | Award | 1,721 | — | — | 8.2K | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Apr 27, 2026 | Sale | 74 | $151.94 | $11.2K | 21.2K | Form 4 ↗ |
Neal Shana Carol EVP and Chief People Officer | Apr 6, 2026 | Tax Withhold | 1,146 | — | — | 24.0K | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Mar 26, 2026 | Sale | 75 | $156.83 | $11.8K | 21.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Becton, Dickinson and Company (BDX) is primarily owned by institutional investors, who hold approximately 71.6% of total shares outstanding. Company insiders own approximately 0.19%, while retail and public investors account for the remaining 28.21%.
The largest institutional shareholder of Becton, Dickinson and Company is VANGUARD GROUP INC, holding approximately 28.00 million shares — equal to 9.71% of outstanding shares — as of March 31, 2025.
A total of 1,654 institutional investors currently hold BDX stock, with a combined institutional value of approximately $59.47 billion as of the most recent 13F filing period.
Frequently asked questions
BDX ownershipBecton, Dickinson and Company (BDX) is primarily owned by institutional investors, who hold approximately 71.6% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.71% stake. Company insiders hold 0.19%. Data sourced from SEC Form 13F as of March 31, 2025.